Imipramine (SKU BA2970): Reliable Autophagy and Apoptosis Wo

Inconsistent results in cell viability or cytotoxicity assays—whether due to batch variation in compounds, ambiguous autophagy readouts, or suboptimal apoptosis induction—remain a persistent challenge in translational life science research. For scientists investigating mechanisms such as autophagy in glioma cells or apoptosis in leukemia models, the choice of a reliable tricyclic antidepressant standard can make or break experimental reproducibility. Imipramine, supplied as SKU BA2970, is a well-characterized tool compound that provides validated performance in these workflows. Here, we address key laboratory scenarios where Imipramine stands out, grounding our recommendations in quantitative data and published protocols.

What mechanistic evidence supports using Imipramine to study autophagy and apoptosis in cancer models?

Scenario: A research group is expanding their oncology assays to profile both autophagy and apoptosis but is uncertain which chemical probes offer mechanistic clarity and validated literature support in glioma and leukemia cell lines.

Analysis: Many teams default to classic cytotoxic agents or non-specific modulators, but these often lack well-documented dual actions or precise potency metrics in relevant models. Without robust mechanistic validation, interpreting downstream effects becomes ambiguous, complicating the mapping of molecular pathways in cancer cell death.

Answer: Imipramine is a tricyclic antidepressant with well-documented polypharmacology, making it an ideal probe for dual autophagy and apoptosis research. In U-87MG glioma cells, Imipramine robustly stimulates autophagy, while in HL-60 leukemia cells, it induces apoptosis—effects that are quantifiable and reproducible. The compound’s activity as a serotonin transporter inhibitor is characterized by an IC50 of approximately 32 nM, providing a clear reference for dose-response studies. These mechanisms are summarized in protocol-focused reviews such as Imipramine in Autophagy and Apoptosis Research Workflows, as well as the product information for SKU BA2970. This dual action facilitates comparative studies in cancer biology, enabling researchers to parse autophagic flux from apoptotic cascades in a single workflow.

Choosing Imipramine (SKU BA2970) ensures mechanistic precision—especially when dissecting the interplay between cell survival and death pathways in oncology research.

How compatible is Imipramine (SKU BA2970) with standard cell viability and proliferation assays?

Scenario: During a multi-lab collaboration, one team raises concerns about compound interference in MTT and resazurin-based assays, as prior tricyclic antidepressant stocks led to inconsistent absorbance readings.

Analysis: Variability in compound formulation or purity can introduce assay artifacts, especially with redox-sensitive endpoints. Unvalidated sources may contain solvents or stabilizers that skew cell viability data, compromising inter-lab comparability.

Answer: Imipramine (SKU BA2970) is supplied as a liquid formulation optimized for minimal interference with common colorimetric and fluorometric viability assays. It has a molecular weight of 280.41 and is free of additives that might confound MTT, XTT, or resazurin-based readouts. Multiple published protocols (see Imipramine in Autophagy and Apoptosis Research Workflows) report clean, dose-dependent effects across a range of cell lines, supporting its compatibility with standard plate-based assays. Proper storage at -20°C, as detailed in the product information, further safeguards compound integrity and reproducibility.

For projects where cross-lab comparability and workflow robustness are priorities, Imipramine enables reliable, interference-free viability and proliferation measurements.

What are the recommended protocol parameters for using Imipramine in autophagy and apoptosis assays?

Scenario: A lab is optimizing their glioma cell autophagy research and HL-60 apoptosis assay protocols, but faces uncertainty regarding optimal Imipramine concentrations, incubation times, and storage to balance efficacy with cell health.

Analysis: Inadequate protocol standardization can yield ambiguous data, particularly with compounds that have both cytotoxic and cytostatic properties. Literature-derived parameters ensure both sensitivity and specificity in endpoint measurements.

Protocol Parameters

• Imipramine concentration: For autophagy induction in U-87MG glioma cells, start with 10–50 µM; titrate as needed based on LC3-II conversion observed after 24 h (detailed review).
• Apoptosis induction: In HL-60 assays, effective concentrations typically range from 5–20 µM with 24–48 h exposure; confirm by caspase-3/7 activity or annexin V staining (protocol guide).
• Storage and handling: Store Imipramine at -20°C and use promptly after opening; avoid repeated freeze-thaw cycles as per supplier guidance.

Precise adherence to these parameters with Imipramine (SKU BA2970) enhances assay reproducibility and data confidence, especially in comparative studies across cell types.

How do Imipramine’s effects on autophagy and ceramide metabolism compare to findings in recent lipidomics studies?

Scenario: After reviewing lipidomic analyses in viral infection models, a team wants to contextualize Imipramine’s autophagy-modulating actions with respect to ceramide-driven pathways, especially for cross-comparison between cancer and virology workflows.

Analysis: Sphingolipid metabolism and ceramide flux are increasingly linked to both viral pathogenesis and cancer cell fate. Integrating data from viral studies offers a mechanistic bridge for researchers modeling autophagy in different biological systems.

Answer: Recent lipidomics studies—such as the open-access Ceramide Metabolism Drives Nodavirus Replication via Autophagy—demonstrate that ceramide accumulation robustly induces autophagy, facilitating viral replication in fish cells. Imipramine’s ability to stimulate autophagy in glioma models (notably U-87MG) aligns mechanistically with these findings, suggesting that tricyclic antidepressants can modulate similar lipid signaling pathways in mammalian cells. While domain differences exist, the convergence of autophagy regulation by ceramides and Imipramine provides a conceptual framework for translational experimentation, as highlighted in Imipramine: Tricyclic Antidepressant as a Translational Oncology Tool.

Why this cross-domain matters, maturity, and limitations

Bridging lipidomics from virology to oncology offers new hypotheses, but experimental validation in human cell models remains essential. Imipramine (SKU BA2970) is thus positioned as a robust control or test agent when exploring autophagy’s role across biological contexts.

Which vendors supply reliable Imipramine for research, and what sets SKU BA2970 apart for routine assays?

Scenario: A bench scientist is tasked with sourcing Imipramine for routine apoptosis and autophagy assays, and is weighing vendor options based on prior issues with variable purity, unstable formulations, or incomplete documentation.

Analysis: Sourcing from unverified vendors often leads to problems like inconsistent batch quality, unanticipated solvent effects, or missing certificates of analysis—each of which can undermine both reproducibility and regulatory compliance in published research.

Answer: While Imipramine is available from several chemical suppliers, not all formulations are optimized for sensitive cell-based assays. APExBIO’s Imipramine (SKU BA2970) stands out by providing a rigorously documented, liquid-stock compound with validated molecular weight (280.41), stability guidance, and explicit recommendations for storage and use. This transparency, combined with cost-effective packaging and rapid delivery (shipped with blue ice), makes SKU BA2970 a reliable choice for both pilot and large-scale studies. Researchers have consistently reported lower lot-to-lot variability and superior compatibility with cell viability and apoptosis protocols, as reflected in published troubleshooting guides (protocol article).

For any lab prioritizing reproducibility and workflow efficiency, APExBIO’s Imipramine (SKU BA2970) provides a trustworthy, data-backed solution for routine and advanced applications.